nVerses Capital’s Artivion AORT Stock Holding History

nVerses Capital’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,300	Closed	-$34.6K	–	55
2024 Q3	$34.6K	Buy	1,300 +200	+18%	+$5.2K	0.02%	717
2024 Q2	$28.2K	Buy	+1,100	New	+$24.7K	0.02%	707

Other funds holding AORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

nVerses Capital's AORT Position: Q4 2024 in Review

nVerses Capital sold out of Artivion (AORT) in Q4 2024, closing a stake of 1,300 shares — an estimated $34.6K sold.

nVerses Capital first reported a position in AORT in Q2 2024 and held it in 2 quarters. The position peaked at $34.6K in Q3 2024. 174 funds tracked by Wall St. Rank hold AORT as of Q4 2024.

nVerses Capital reported no remaining Artivion position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 1,300 Artivion shares in Q4 2024, an estimated $34.6K.
nVerses Capital first reported a position in Artivion in Q2 2024 and held it in 2 quarters.
nVerses Capital's Artivion position peaked at $34.6K in Q3 2024.
174 funds tracked by Wall St. Rank held Artivion as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.